Your browser doesn't support javascript.
loading
A Systematic Review Unraveling the Intricate Neurological Spectrum of COVID-19: Manifestations, Complications, and Transformative Insights for Patient Care.
Pitliya, Aakanksha; Dhamecha, Jatin; Kumar, Deepak; Anusha, Kvn; Kancherla, Neeraj; Kumar, Lakshya; Singla, Ramit; Pitliya, Anmol.
Afiliação
  • Pitliya A; Department of Medicine, Pamnani Hospital and Research Center, Mandsaur, MP, India.
  • Dhamecha J; Department of Medicine, Government Medical College, Bhavnagar, Gujarat, India.
  • Kumar D; Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan.
  • Anusha K; Department of Medicine, Jawaharlal Nehru Medical College, Belgaum, Karnataka, India.
  • Kancherla N; Department of Medicine, King George Hospital, Visakhapatnam, AP, India.
  • Kumar L; Department of Medicine, Pandit Deendayal Upadhyay Medical College, Rajkot, Gujarat, India.
  • Singla R; Department of Neurology, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Pitliya A; Department of Internal Medicine, Camden Clark Medical Center/University of West Virginia, Parkersburg, WV, USA.
Neurol India ; 72(1): 11-19, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-38442994
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic has strained global healthcare and financial infrastructures. Neurological manifestations of COVID-19 have gained recognition, emphasizing the need for comprehensive research in this area. This systematic review aims to comprehensively examine the neurological manifestations and complications associated with COVID-19 and assess their prevalence, impact on patient outcomes, and potential relationships with comorbidities, while emphasizing the significance of ongoing research in this field. We conducted a systematic review using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) 2020 guidelines. A comprehensive search of PubMed, Google Scholar, Science Direct, and ResearchGate databases was conducted to identify eligible studies focusing on COVID-19 patients, reporting neurological symptoms or complications, and published between 2020 and 2022 in English. The data extracted is performed in a Microsoft Excel spreadsheet. Two independent reviewers assessed study quality and bias using the AMSTAR 2 scale before inclusion. This systematic includes 12 systematic reviews and meta-analysis with 191,412 participants and average age of 60 years. Neurological symptoms included headaches, dizziness, anosmia, and ageusia. Complications ranged from cerebrovascular events to Guillain-Barré syndrome. Comorbidities, such as hypertension and diabetes, exacerbated severity. Mortality rates associated with neurological manifestations varied from 29.1% to 84.8%. The study underscores the complex neurological impact of COVID-19, affecting patients across age groups. Ongoing research is vital to understand mechanisms and develop targeted interventions, improving patient care and addressing pandemic consequences. This review provides a holistic view of COVID-19's neurological effects, emphasizing the need for sustained research efforts and collaborative endeavors to combat the neurological issues.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Doenças do Sistema Nervoso Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Doenças do Sistema Nervoso Idioma: En Ano de publicação: 2024 Tipo de documento: Article